Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical research, government and academic laboratories. The biopharmaceutical industry is specifically supported by novel separation technology designed and manufactured for the analysis of biologics. Incorporating a novel biocompatible titanium hardware, the bioZen™ product series includes two particle platforms spanning seven chemistries, which provides ultimate flexibility for the UHPLC and HPLC characterization of biotherapeutics, such as monoclonal antibodies, antibody-drug conjugates and biosimilars. This product series includes solutions for the analysis of aggregates and total mAb, intact mass and fragments, peptide mapping and quantitation, and glycan mapping.
The rigorous quality standards at Phenomenex ensure reproducibility for analytical scientists across all industries. From drug discovery and pharmaceutical development, to food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being.